University Study Center for Metabolic Diseases
Dresden, Saxony, 01307, Germany
Location status: Recruiting
NCT Number: NCT06396871
The goal of this cross-sectional observational study is to to perform a thorough characterization of the quantitative and qualitative differences in peripheral blood cells, and circulating factors (proteins, metabolites, lipids, extracellular vesicles) in different stages of several metabolic diseases (diabetes, obesity, non-alcoholic fatty liver disease) that share common pathophysiological mechanisms and in comparison with adult healthy controls. The main question[s] it aims to answer are:
* Which are the quantitative (number and concentration) and qualtitative (characteristics, functional assays) differences in platelets in patients with metabolic diseases vs subjects without metabolic diseases * Which are the quantitative (number and concentration) and qualtitative (characteristics, functional assays) differences in leucocytes or circulating molecules in patients with metabolic diseases vs subjects without metabolic diseases
Interested in participating?
Request Info18 year and older
All sexes
Observational
Dresden, Saxony, 01307, Germany
Location status: Recruiting
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Additional inclusion criteria for case groups:
If a subject does not fulfil the additional criteria for participating in a case group, then he/she will be included in the respective control group which will be:
A#) Low risk for significant liver fibrosis 1. Fibroscan measurements < 8kPa B#) No steatosis group
Exclusion criteria
Additional exclusion criteria for MRI:
75g of a standardized glucose solution followed by blood draw at 0, 30, 60, 90, 120 min
A crude assessment of liver status in order to identify the presence of steatosis or not will take place with ultrasound.
FibroScan non-invasively measures the stiffness of the liver by capturing and calculating the speed of a shear wave as it travels through the liver (vibration controlled transient elastography).
The exact calculation of liver fat with proton density fat fraction will take place with MRI.
Time frame: 1 day
% of Platelet aggregation
Time frame: 1 day
Platelet count in GPt/L
Time frame: 1 day
Leucocyte count in GPt/L
Time frame: 1 day
Neutrophil count in GPt/L
Time frame: 1 day
Lymphocyte count in GPt/L
Time frame: 1 day
Monocyte count in GPt/L
Time frame: 1 day
% of neutrophils performing NETosis (FACS analysis)
Time frame: 1 day
% of neutrophils performing phagocytosis (FACS analysis)
Time frame: 1 day
% of monocytes performing phagocytosis (FACS analysis)
Time frame: 1 day
Interleukin-6 in pg/ml
Time frame: 1 day
Interleukin-8 in pg/ml
Interested in participating?
Request InfoTechnische Universität Dresden
Other
Acronym: PERIMED
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06697977
Body Weight, Diabetes
Amman, Jordan
View Trial DetailsNCT02663544
Body Weight, Diabetes
Seattle, Washington, United States
View Trial DetailsNCT06186869
Behavior, Body Weight
Castellana Grotte, Bari, Italy
View Trial DetailsNCT06599918
Body Weight, Digestive System Diseases
Barcelona, Spain
View Trial Details